Tag: Oncologists

Advisory Board Applauds On-Demand Approach of OptraSCAN

| July 19, 2017 | 0 Comments

OptraSCAN has given tissuepathology.com a rare insight into their advisory board discussions as to what their thought leaders think is important in the digital pathology space for the market. OptraSCAN is of course the first On-Demand digital pathology company that includes a small footprint, high and low throughput WSI scanner OptraSCANTM (that facilitates brightfield, fluorescent and frozen section/live view scanning), […]

Continue Reading

Oncologists Say Genomic Testing Is Over Promoted Though It Is Likely To Be Useful Over The Next Decade

Fierce Healthcare (5/2, Sweeney) reports on a Medscape survey finding that among oncologists, about 70% “believe genetic testing is very important or extremely important to oncology, but 55% also say genomic testing is overpromoted.” One reason for that is that 89% believe “genomics will be useful in the next decade,” while just 64% “say it’s […]

Continue Reading